[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f_ZxWH4vgbUTc3o_Ijd8MaFdKmt2F10ajgphglyOl3Qw":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":8,"totalEnrollment":9,"activePrograms":8,"nonDrugCount":10,"topConditions":11,"upcomingReadouts":31,"phaseBuckets":32,"rows":39},"Cynosure, Inc.",[4],52,false,0,1236,51,[12,15,17,20,22,25,27,29],{"name":13,"count":14},"Acne Scars",7,{"name":16,"count":14},"Wrinkle",{"name":18,"count":19},"Wrinkles",4,{"name":21,"count":19},"Scars",{"name":23,"count":24},"Melasma",3,{"name":26,"count":24},"Fine Lines",{"name":28,"count":24},"Crepey Skin",{"name":30,"count":24},"Enlarged Pores",[],[33,34,35,36,37,38],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[40],{"intervention":41,"totalTrials":42,"cells":43},"Topical Cosmeceuticals",1,{"EARLY_PHASE1":44,"PHASE1":46,"PHASE2":48,"PHASE3":50,"PHASE4":52,"NA":54},{"trials":45,"activeCount":8},[],{"trials":47,"activeCount":8},[],{"trials":49,"activeCount":8},[],{"trials":51,"activeCount":8},[],{"trials":53,"activeCount":8},[],{"trials":55,"activeCount":8},[56],{"nctId":57,"briefTitle":58,"status":59,"phases":60,"primaryCompletion":61,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":68},"NCT05102617","Post Market Usability Evaluation Of The PicoSure Pro Device","COMPLETED",[38],"2023-03-15","2021-10-21",23,[16,13,65,66,67],"Benign Epidermal Pigmented Lesions","Benign Dermal Pigmented Lesions","Tattoo Removal",[41]]